ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 376254 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 376254; 2) Community: the network communities that were significantly associated with the response to NSC 376254; 3) Molecule: the relationships between components within communities and NSC 376254; 4) MDR: the compounds that were significantly associated with the NSC 376254.

NSC Compound Enrichment Correlation
NSC 693543 4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride 0.00888636978630782 0.44601875
NSC 740973 6-(3-Azidopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00888636978630782 0.55528058
NSC 751393 2-(4,5-dibenzoyl-1,3-dithiol-2-ylidene)-1-ethyl-6-(phenylimino)-3-thioxo-2,3-dihydro-1H-thieno[2,3-b][1,4]thiazin-7(6H)-one 0.00888636978630782 0.58633649
NSC 343499 CI-921: amsacrine derivative 0.00888636978630788 0.63428289
NSC 364830 Camptothecin Derivative 0.00888636978630788 0.60425638
NSC 329250 Null 0.0102077332082016 0.16399722
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0102077332082017 0.26710884
NSC 697166 4H-1,2,4-Triazol-4-amine, 3,3'-(1,8-octanediyl)bis[5-[(4-chlorophenoxy)methyl]- N-phenyl- 0.0102077332082017 0.07360339
NSC 703749 Null 0.0102077332082017 -0.0061670686
NSC 295501 Camptothecin Derivative 0.0102962192514438 0.58999933
Total:47  Current:9    [First] [Prev] [Next] [Last]